Jacob V. Gorman

1.2k total citations · 1 hit paper
10 papers, 975 citations indexed

About

Jacob V. Gorman is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jacob V. Gorman has authored 10 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 3 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Jacob V. Gorman's work include Galectins and Cancer Biology (6 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Immunotherapy and Immune Responses (2 papers). Jacob V. Gorman is often cited by papers focused on Galectins and Cancer Biology (6 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Immunotherapy and Immune Responses (2 papers). Jacob V. Gorman collaborates with scholars based in United States and Japan. Jacob V. Gorman's co-authors include John Colgan, Yoichiro Fujioka, Ichiro Kinoshita, Akinori Takaoka, Toshimitsu Uede, Masahisa Jinushi, Shigeki Chiba, Hironori Yoshiyama, Yusuke Ohba and Mitsuomi Hirashima and has published in prestigious journals such as The Journal of Experimental Medicine, Nature Immunology and The Journal of Immunology.

In The Last Decade

Jacob V. Gorman

9 papers receiving 962 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

2012 669 citations Shigeki Chiba, Muhammad Baghdadi et al. Nature Immunology profile →

Peers

Countries citing papers authored by Jacob V. Gorman

Since Specialization

Citations

This map shows the geographic impact of Jacob V. Gorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob V. Gorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob V. Gorman more than expected).

Fields of papers citing papers by Jacob V. Gorman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob V. Gorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob V. Gorman. The network helps show where Jacob V. Gorman may publish in the future.

Co-authorship network of co-authors of Jacob V. Gorman

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob V. Gorman. A scholar is included among the top collaborators of Jacob V. Gorman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob V. Gorman. Jacob V. Gorman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Sequential JAK inhibition enhances antitumor immunity after combined anti–PD-1 and anti-CTLA4 2025 ·JCI Insight ·Marcel Arias-Badia, Peixi Chen, (unknown), (unknown), Aram Lyu, (unknown), Serena S. Kwek, (unknown), (unknown), (unknown), Matthew D. Clark, Averey Lea, (unknown), Andrew Goodearl, Fiona Harding, Jacob V. Gorman, (unknown), Lawrence Fong	2
2	Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells 2023 ·Journal for ImmunoTherapy of Cancer ·Yue Liu, (unknown), Donald J. Wolfgeher, (unknown), Jacob V. Gorman, Stephen J. Kron	25
3	Reciprocal SH2-SH3 Domain Contacts between ITK Molecules Limit T Cell Receptor Signaling in Th2-type CD4⁺ T Cells 2021 ·Immunological Investigations ·Ji‐Long Chen, (unknown), (unknown), Jacob V. Gorman, John Colgan	0
4	Acute stimulation generates Tim‐3‐expressing T helper type 1 CD 4 T cells that persist in vivo and show enhanced effector function 2018 ·Immunology ·Jacob V. Gorman, John Colgan	13
5	Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways 2016 ·Scientific Reports ·Ling–Ling An, Jacob V. Gorman, Geoffrey L. Stephens, (unknown), Paul Warrener, Jessica Bonnell, Tomas Mustelin, Michael Fung, Roland Kolbeck	29
6	Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation 2015 ·The Journal of Experimental Medicine ·Binh Phong, Lyndsay Avery, Tina L. Sumpter, Jacob V. Gorman, Simon C. Watkins, John Colgan, Larry Kane	86
7	Tim-3 Directly Enhances CD8 T Cell Responses to Acute Listeria monocytogenes Infection 2014 ·The Journal of Immunology ·Jacob V. Gorman, Gabriel R. Starbeck-Miller, Nhat‐Long Pham, Geri Traver, Paul B. Rothman, John T. Harty, John Colgan	64
8	Regulation of T cell responses by the receptor molecule Tim-3 2014 ·Immunologic Research ·Jacob V. Gorman, John Colgan	65
9	Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 breakdown → 2012 ·Nature Immunology ·Shigeki Chiba, Muhammad Baghdadi, Hisaya Akiba, Hironori Yoshiyama, Ichiro Kinoshita, Hirotoshi Dosaka‐Akita, Yoichiro Fujioka, Yusuke Ohba, Jacob V. Gorman, John Colgan, Mitsuomi Hirashima, Toshimitsu Uede, Akinori Takaoka, Hideo Yagita∥, Masahisa Jinushi	669
10	Tim‐1 regulates Th2 responses in an airway hypersensitivity model 2011 ·European Journal of Immunology ·Miranda L. Curtiss, Jacob V. Gorman, Thomas R. Businga, Geri Traver, (unknown), David K. Meyerholz, Joel N. Kline, Andrew Murphy, David M. Valenzuela, John Colgan, Paul B. Rothman, Suzanne L. Cassel	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact